Get the Stockscreener App
1.73
11.61%
0.18
Sl Science Holding Ltd stock is traded at $1.73, with a volume of 108.97K.
It is up +11.61% in the last 24 hours and down -9.42% over the past month.
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
See More
Previous Close:
$1.55
Open:
$1.55
24h Volume:
108.97K
Relative Volume:
2.08
Market Cap:
$970.11M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
+13.82%
1M Performance:
-9.42%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$1.53
$1.75
1-Week Range:
$1.47
$1.62
52-Week Range:
$1.42
$14.50
Sl Science Holding Ltd Stock (SLBT) Company Profile
Compare SLBT vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLBT
Sl Science Holding Ltd
|
1.73 | 970.11M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.37 | 128.85B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
239.43 | 95.59B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
799.68 | 82.33B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
852.36 | 53.60B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
373.96 | 42.30B | 5.76B | 514.49M | 1.10B | 4.4813 |
Sl Science Holding Ltd Stock (SLBT) Latest News
The CEO buys 4.55M ordinary shares in SL Science Holding (SLBT). - Stock Titan
A CEO buys shares without changing his total ownership in SL Science Holding (SLBT). - Stock Titan
SLBT Price Today: SL Science Holding Limited Stock Price, Quote & Chart | MEXC - MEXC
Business council charts new SL–Canada trade drive - Island.lk
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Sl Science Holding Ltd stock hits 52-week low at 2.45 USD - Investing.com Canada
Sl Science Holding Ltd stock hits 52-week low at 2.45 USD By Investing.com - Investing.com South Africa
Sl Science Holding Ltd stock hits 52-week low at 2.45 USD - investing.com
September 2026 Nasdaq Stock Market Bell Ceremonies - Nasdaq
Morning Market Movers: RARE, BIAF, TLYS, SNOW See Big Swings - RTTNews
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
NetApp, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session - Benzinga
Why Snowflake Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket - Benzinga
SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company - The Manila Times
SL Science Rings Nasdaq Bell, Marks First Quarter as Public Company and Advances γδ T Cell Therapy Platform - Quiver Quantitative
SL Science Rings Nasdaq Bell, Marks First Quarter as Public Company and Advances γδ T Cell Therapy Platform - Quiver Quantitative
SL Science Holding Discloses Resignation of Vice President of Finance - theglobeandmail.com
Johnson Lau Steps Down as VP of Finance at SL Science Holding Ltd - Kalkine Media
SL Science Holding Discloses Resignation of Vice President of Finance - TipRanks
SL Science (SLBT) finance VP steps down with no insider trades - Stock Titan
SL Science (SLBT) finance VP to step down Aug. 31 - Stock Titan
SL Science licensor files exosome drug master file with FDA - Investing.com India
SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform - manilatimes.net
A new FDA filing covers exosomes; studies indicate they can cross the blood-brain barrier - Stock Titan
SL Science licensor files exosome drug master file with FDA - investing.com
SL Science Holding Ltd Switches Audit Firm to TAAD LLP in Late August 2026 - TipRanks
SL Science Holding (SLBT) Stock May Be Fully Priced Even After A 74% Fall - Yahoo Finance
SL Science Holding Limited Ordinary Shares (NASDAQ: SLBT) Stock Price, News & Analysis - kalkine.com.au
SL Science Holding Limited Ordinary Shares (NASDAQ: SLBT) Stock Price, News & Analysis - kalkine.ca
SL Science Holding Ltd SEC Filing (Aug 13, 2026) - Stock Titan
Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance
RBGLY Stock Price and Chart — OTC:RBGLY - TradingView
SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in Glioblastoma - The Manila Times
SL Science Holding Limited Announces Publication of Peer-Reviewed Framework for γδ T Cell Therapy in Glioblastoma - Quiver Quantitative
Brain Cancer Cell Therapy Trials Must Track Cells, Review Says - Stock Titan
Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance
AbCellera Stock Soars 30% After Menopause Drug ABCL635 Hits Phase 2 Success In Hot Flash Trial Results - International Business Times Australia
Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance
Upcoming and recent IPOs – IPOs calendar - Yahoo Finance UK
Operating expenses (excl. COGS) of SL Science Holding Limited – NASDAQ:SLBT - TradingView
SL Science Holding Ord Shs (SLBT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
SL Science Holding (NASDAQ: SLBT) files to register resale of 1.04M shares - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Saol Therapeutics Announces the Acceptance of Resubmission of SL1009 (DCA) by the FDA with PDUFA Date of Dec. 30, 2026 - Yahoo Finance
SL Science Holding Ord Shs (SLBT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SLBT|SL Science Holding Ord Shs|Price:3.200|Chg%:+0.555 - TradingKey
SL Science Holding Ord Shs (SLBT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SL Science Holding Ord Shs (SLBT) Cash Flow - TradingKey
SL Science Holding Ord Shs (SLBT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sl Science Holding Ltd Stock (SLBT) Financials Data
There is no financial data for Sl Science Holding Ltd (SLBT). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.42%
10.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):